天然免疫系统在心脏缺血再灌注损伤及其保护作用中的研究进展
摘要
天然免疫系统的激活和炎性反应是缺血再灌注损伤的重要特征,其在心肌缺血再灌注损伤中的重要作用日益受到关注。缺血预处理和缺血后处理是缺血心肌有效的内源性保护现象,具有显著的抗缺血再灌注损伤作用。现就天然免疫系统在心肌缺血再灌注及其保护作用的研究进展予以综述。
引文
[1]BONAVENTURA A,MONTECUCCO F,DALLEGRIF.Cellular recruitment in myocardial ischaemia/reperfusion injury[J].Eur J Clin Invest,2016,46(6):590-601.
[2]JIAN J,XUAN F,QIN F,et al.The antioxidant,anti-inflammatory and anti-apoptotic activities of the bauhinia championii flavone are connected with protection against myocardial ischemia/reperfusion iInjury[J].Cell Physiol Biochem,2016,38(4):1365-1375.
[3]RAI V,AGRAWAL D K.The Role of DAMPs and PAMPs in inflammation-mediated vulnerability of atherosclerotic plaques[J].Can J Physiol Pharmacol,2017,95(10):1245-1253.
[4]TOLDO S,QUADER M,SALLOUM F N,et al.Targeting the innate immune response to improve cardiac graft recovery after heart transplantation:implications for the donation after cardiac death[J].Int J Mol Sci,2016,17(6):958.
[5]LU M,TANG F,ZHANG J,et al.AstragalosideⅣattenuates injury caused by myocardial ischemia/repeffusion in rats via regulation of toll-like receptor 4/nuclear factorkappa B signaling pathway[J].Phytother Res,2015,29(4):599-606.
[6]LI X,YANG J,YANG J,et al.RP105protects against myocardial ischemia-reperfusion injury via suppressing TLR4signaling pathways in rat model[J].Exp Mol Pathol,2016,100(2):281-286.
[7]YANG J,YANG C,YANG J,et al.RP105alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways[J].Int J Mol Med,2018,41(6):3287-3295.
[8]BAGCHI A K,AKOLKAR G,MANDAL S,et al.Tolllike receptor 2 dominance over Toll-like receptor 4in stressful conditions for its detrimental role in the heart[J].Am J Physiol Heart Circ Physiol,2017,312(6):H1238-H1247.
[9]ARSLAN F,SMEETS MB,O′NEILL LA,et al.Myocardial ischemia/reperfusion injury is mediated by leukocyte toll-like receptor-2and reduced by systemic administration of a novel anti-TLR-2antibody[J].Circulation,2010,121(1):80-90.
[10]XIE L,LIU S,CHENG J,WANG L,et al.Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway[J].Regul Toxicol Pharmacol,2017,89(1):148-154.
[11]ZHOU D C,SU Y H,JIANG F Q,et al.CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis[J].J Cell Physiol,2018,233(5):4245-4257.
[12]DONG J W,VALLEJO J G,TZENG H P,et al.Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways[J].Am J Physiol Heart Circ Physiol,2010,298(3):H1079-H1087.
[13]POURRAJAB F,YAZDI M B,ZARCH M B,et al.Cross talk of the first-line defense TLRs with PI3K/Akt pathway,in preconditioning therapeutic approach[J].Mol Cell Ther,2015,3(1):4.
[14]LEE S M,HUTCHINSON M,SAINT D A.The role of Toll-like receptor 4(TLR4)in cardiac ischaemic-reperfusion injury,cardioprotection and preconditioning[J].Clin Exp Pharmacol Physiol,2016,43(9):864-871.
[15]ZHANG J,ZHANG J,YU P,et al.Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via inhibition TLR4/MyD88/NF-κB signaling pathway[J].Cell Physiol Biochem,2017,41(1):22-32.
[16]YANG Y F,PENG K,LIU H,et al.Dexmedetomidine preconditioning for myocardial protection in ischaemiareperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factorκB signalling pathway[J].Clin Exp Pharmacol Physiol,2017,44(3):353-361.
[17]WANG C,SUN H,SONG Y,et al.Pterostilbene attenuates inflammation in rat heart subjected to ischemiareperfusion:role of TLR4/NF-κB signaling pathway[J].Int J Clin Exp Med,2015,8(2):1737-1746.
[18]VANEZIS A P,RODRIGO G C,SQUIRE I B,et al.Remote ischaemic conditioning and remodelling following myocardial infarction:current evidence and future perspectives[J].Heart Fail Rev,2016,21(5):635-643.
[19]KIM S C,WU S,FANG X,et al.Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model[J].Life Sci,2014,119(1/2):1-8.
[20]SHARIF-PAGHALEH E,YAP M L,PUHL S L,et al.Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury[J].Sci Rep,2017,7(1):16090.
[21]DE HOOG V C,TIMMERS L,VAN DUIJVENVOORDEA,et al.Leucocyte expression of complement C5areceptors exacerbates infarct size after myocardial reperfusion injury[J].Cardiovasc Res,2014,103(4):52152-52159.
[22]YAMAMOTO T,TAMAKI K,SHIRAKAWA K,et al.Cardiac Sirt1mediates the cardioprotective effect of caloric restriction by suppressing local complement system activation after ischemia-reperfusion[J].Am J Physiol Heart Circ Physiol,2016,310(8):H1003-H1014.
[23]CHUN N,HADDADIN A S,LIU J,et al.Activation of complement factor B contributes to murine and human myocardialischemia/reperfusion injury[J].PLoS One,2017,12(6):e0179450.
[24]TANG K,CHENG Y,WU S,et al.Protective effect of C5shRNA on myocardial ischemia-reperfusion injury in rats[J].Can J Physiol Pharmacol,2012,90(10):1394-1402.
[2]JIAN J,XUAN F,QIN F,et al.The antioxidant,anti-inflammatory and anti-apoptotic activities of the bauhinia championii flavone are connected with protection against myocardial ischemia/reperfusion iInjury[J].Cell Physiol Biochem,2016,38(4):1365-1375.
[3]RAI V,AGRAWAL D K.The Role of DAMPs and PAMPs in inflammation-mediated vulnerability of atherosclerotic plaques[J].Can J Physiol Pharmacol,2017,95(10):1245-1253.
[4]TOLDO S,QUADER M,SALLOUM F N,et al.Targeting the innate immune response to improve cardiac graft recovery after heart transplantation:implications for the donation after cardiac death[J].Int J Mol Sci,2016,17(6):958.
[5]LU M,TANG F,ZHANG J,et al.AstragalosideⅣattenuates injury caused by myocardial ischemia/repeffusion in rats via regulation of toll-like receptor 4/nuclear factorkappa B signaling pathway[J].Phytother Res,2015,29(4):599-606.
[6]LI X,YANG J,YANG J,et al.RP105protects against myocardial ischemia-reperfusion injury via suppressing TLR4signaling pathways in rat model[J].Exp Mol Pathol,2016,100(2):281-286.
[7]YANG J,YANG C,YANG J,et al.RP105alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways[J].Int J Mol Med,2018,41(6):3287-3295.
[8]BAGCHI A K,AKOLKAR G,MANDAL S,et al.Tolllike receptor 2 dominance over Toll-like receptor 4in stressful conditions for its detrimental role in the heart[J].Am J Physiol Heart Circ Physiol,2017,312(6):H1238-H1247.
[9]ARSLAN F,SMEETS MB,O′NEILL LA,et al.Myocardial ischemia/reperfusion injury is mediated by leukocyte toll-like receptor-2and reduced by systemic administration of a novel anti-TLR-2antibody[J].Circulation,2010,121(1):80-90.
[10]XIE L,LIU S,CHENG J,WANG L,et al.Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway[J].Regul Toxicol Pharmacol,2017,89(1):148-154.
[11]ZHOU D C,SU Y H,JIANG F Q,et al.CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis[J].J Cell Physiol,2018,233(5):4245-4257.
[12]DONG J W,VALLEJO J G,TZENG H P,et al.Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways[J].Am J Physiol Heart Circ Physiol,2010,298(3):H1079-H1087.
[13]POURRAJAB F,YAZDI M B,ZARCH M B,et al.Cross talk of the first-line defense TLRs with PI3K/Akt pathway,in preconditioning therapeutic approach[J].Mol Cell Ther,2015,3(1):4.
[14]LEE S M,HUTCHINSON M,SAINT D A.The role of Toll-like receptor 4(TLR4)in cardiac ischaemic-reperfusion injury,cardioprotection and preconditioning[J].Clin Exp Pharmacol Physiol,2016,43(9):864-871.
[15]ZHANG J,ZHANG J,YU P,et al.Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via inhibition TLR4/MyD88/NF-κB signaling pathway[J].Cell Physiol Biochem,2017,41(1):22-32.
[16]YANG Y F,PENG K,LIU H,et al.Dexmedetomidine preconditioning for myocardial protection in ischaemiareperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factorκB signalling pathway[J].Clin Exp Pharmacol Physiol,2017,44(3):353-361.
[17]WANG C,SUN H,SONG Y,et al.Pterostilbene attenuates inflammation in rat heart subjected to ischemiareperfusion:role of TLR4/NF-κB signaling pathway[J].Int J Clin Exp Med,2015,8(2):1737-1746.
[18]VANEZIS A P,RODRIGO G C,SQUIRE I B,et al.Remote ischaemic conditioning and remodelling following myocardial infarction:current evidence and future perspectives[J].Heart Fail Rev,2016,21(5):635-643.
[19]KIM S C,WU S,FANG X,et al.Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model[J].Life Sci,2014,119(1/2):1-8.
[20]SHARIF-PAGHALEH E,YAP M L,PUHL S L,et al.Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury[J].Sci Rep,2017,7(1):16090.
[21]DE HOOG V C,TIMMERS L,VAN DUIJVENVOORDEA,et al.Leucocyte expression of complement C5areceptors exacerbates infarct size after myocardial reperfusion injury[J].Cardiovasc Res,2014,103(4):52152-52159.
[22]YAMAMOTO T,TAMAKI K,SHIRAKAWA K,et al.Cardiac Sirt1mediates the cardioprotective effect of caloric restriction by suppressing local complement system activation after ischemia-reperfusion[J].Am J Physiol Heart Circ Physiol,2016,310(8):H1003-H1014.
[23]CHUN N,HADDADIN A S,LIU J,et al.Activation of complement factor B contributes to murine and human myocardialischemia/reperfusion injury[J].PLoS One,2017,12(6):e0179450.
[24]TANG K,CHENG Y,WU S,et al.Protective effect of C5shRNA on myocardial ischemia-reperfusion injury in rats[J].Can J Physiol Pharmacol,2012,90(10):1394-1402.